We talk with Dr. Denise Aberle, a principal investigator on the CT-for-lung-cancer-screening trial that the National Cancer Institute stopped last week. NCI stopped the trial when the trial’s monitoring committee found a 20% decrease in lung cancer deaths among those randomized to CT screening.

Listen in for a fascinating look at what happens when trials stop — and most especially for the implications of this one.

Please make your comments here on the website.

Interview-related links: